ACOR News and Press, Acorda Therapeutics Inc. From 05/08/23

2023-05-08 09:48:32 ET Acorda Therapeutics ( NASDAQ: ACOR ) and Hangzhou Chance Pharmaceuticals announced a distribution and supply agreement for INBRIJA in China. ( ACOR ) is up 7% . INBRIJA is used in the United States for treating adult patients with Parkinson's d...

Acorda Therapeutics, Inc. (Nasdaq: ACOR) and Hangzhou Chance Pharmaceuticals Co. Ltd. today announced that they have entered into distribution and supply agreements to provide INBRIJA ® in China. INBRIJA is indicated in the United States for the intermittent treatment of episodic motor f...

Acorda Therapeutics, Inc. (Nasdaq: ACOR) will host a webcast/conference call in conjunction with its first quarter 2023 update and financial results on Thursday, May 11 at 4:30 p.m. ET. To participate in the Webcast, please use the following registration link: https://events.q4inc.com...

2023-05-02 11:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it will present data on INBRIJA (levodopa inhalation powder) and OFF Periods at the American Academy of Neurology (AAN) Annual Meeting, taking place in Boston from April 22 to April 27, 2023. The poster, “Subgroup Analyses o...

2023-04-13 04:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-04-03 13:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it has launched an INBRIJA ® (levodopa inhalation powder) television commercial for Parkinson’s Awareness Month. The commercial will air on approximately 50 streaming services, including Hulu, the Disney Channel, an...

2023-03-27 16:41:17 ET MannKind ( NASDAQ: MNKD ) on Monday said Lauren Sabella has joined the company as EVP and chief operating officer. Prior to joining the company, Sabella was at Acorda Therapeutics for 12 years, where she last served as COO. Pres...

April 4, 2023 at 1pm ET, 10am PT Participants Invited to Submit Questions to the CEO Acorda Therapeutics, Inc. (Nasdaq: ACOR) will hold a virtual, video Q&A with its CEO, Ron Cohen, M.D., on Tuesday, April 4 at 1:00pm ET, 10:00am PT. Dr. Cohen will present an overview of...